GI
BIIB icon

GS Investments’s Biogen BIIB Stock Holding History

GS Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-500
Closed -$145K – 119
2019
Q4 		$145K Buy
+500
New +$139K 0.12% 75
2018
Q3 		– Sell
-500
Closed -$145K – 121
2018
Q2 		$145K Buy
+500
New +$141K 0.11% 78
2018
Q1 		– Sell
-500
Closed -$159K – 115
2017
Q4 		$159K Hold
500
– – 0.12% 73
2017
Q3 		$157K Hold
500
– – 0.13% 76
2017
Q2 		$136K Buy
+500
New +$132K 0.1% 76

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GS Investments's BIIB Position: Q1 2020 in Review

GS Investments sold out of Biogen (BIIB) in Q1 2020, closing a stake of 500 shares — an estimated $145K sold.

GS Investments first reported a position in BIIB in Q2 2017 and held it in 5 quarters. The position peaked at $159K in Q4 2017. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • GS Investments reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
  • GS Investments sold 500 Biogen shares in Q1 2020, an estimated $145K.
  • GS Investments first reported a position in Biogen in Q2 2017 and held it in 5 quarters.
  • GS Investments's Biogen position peaked at $159K in Q4 2017.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on GS Investments's 13F filing for Q1 2020, filed 7 May 2020.